SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : EntreMed (ENMD)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BARRY ALLEN who wrote (569)5/4/1998 7:57:00 PM
From: Jeff Briley   of 2135
 
BLSI CEO on CNBC at 9:15 E.S.T. tomorrow. In BLSI Press Release today,
the CEO stated that, "We do have a technology called Troponin that works
in a similar manner to Entremed's technology." He also stated, "We hope
to file an IND (investigational new drug application) during the second
half of the year seeking permission to go into clinical trials."

ENMD BLSI
Market Cap(M) 143.7 28.62
Shares Oustanding(M) 12.23 12.72
Float (M) 5.90 10.20
3 month Avg. Daily Vol.(M) .06 .06
Book Value 3.60 1.47
Sales/Share .39 .01
Cash/Share 3.76 1.27
Earnings/Share -.53 -.68
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News